"
Virological and Molecular Profile of People Living with the Human Immunodeficiency Virus Starting Dolutegravir Based Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo"
written by Berry I. Bongenya, Charlotte L. Tshinguta, Marie-Thérèse A. S. Sombo, Guy M. M. Bumoko, Benoit O. Kabengele, Gauthier K. Mesia, Erick N. Kamangu,
published by
World Journal of AIDS,
Vol.13 No.3, 2023
has been cited by the following article(s):
|
[1]
|
Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa
Advances in Infectious Diseases,
2023
DOI:10.4236/aid.2023.134054
|
|
|
|
|
[2]
|
Virological Profile of People Living with HIV after 12 Months of Treatment with Dolutegravir in Kinshasa
World Journal of AIDS,
2023
DOI:10.4236/wja.2023.134014
|
|
|
|
|
[3]
|
Virological and Molecular Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa
World Journal of AIDS,
2023
DOI:10.4236/wja.2023.134013
|
|
|
|